|
| |
| | | 65643 | | 15.08.2016 | | Actelion Pharmaceuticals Ltd | | | | | | | | | | | | | 02.07.10. | | | | 02.07.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Uptravi 200 mcg | Filmtabletten | Coated tablets ( 0.2 mg) | B01AC27 | CI | | 02 | Uptravi 400 mcg | Filmtabletten | Coated tablets ( 0.4 mg) | B01AC27 | CI | | 03 | Uptravi 600 mcg | Filmtabletten | Coated tablets ( 0.6 mg) | B01AC27 | CI | | 04 | Uptravi 800 mcg | Filmtabletten | Coated tablets ( 0.8 mg) | B01AC27 | CI | | 05 | Uptravi 1000 mcg | Filmtabletten | Coated tablets ( 1 mg) | B01AC27 | CI | | 06 | Uptravi 1200 mcg | Filmtabletten | Coated tablets ( 1.2 mg) | B01AC27 | CI | | 07 | Uptravi 1400 mcg | Filmtabletten | Coated tablets ( 1.4 mg) | B01AC27 | CI | | 08 | Uptravi 1600 mcg | Filmtabletten | Coated tablets ( 1.6 mg) | B01AC27 | CI |
|
|
|
